Oculis Holding AG
Licaminlimab
dry eye disease (DED)
Countdown
177days
Phase 2 readout · ~ Dec 31, 2026 estimated
What's at stake
Phase 2 trial results for Licaminlimab in dry eye disease (DED) are due ~ Dec 31, 2026. A clean hit validates the program; a miss can gap the stock down hard.
Primary source
· SEC 6-K
verified 12h ago
“topline results (TLR) are expected to read out around year-end.”